INmune Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SIO CAPITAL MANAGEMENT, LLC | 08/13/2025 | 1.30 M | $3.00 M | 100.00% | 5.58% |
BLACKROCK, INC. | 08/12/2025 | 1.17 M | $2.71 M | 23.63% | 5.03% |
CAPTION MANAGEMENT, LLC | 08/14/2025 | 634.40 K | $1.47 M | 100.00% | 2.72% |
AFFINITY ASSET ADVISORS, LLC | 08/13/2025 | 354.00 K | $817.74 K | 100.00% | 1.52% |
RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 333.48 K | $770.33 K | -12.71% | 1.43% |
08/14/2025 | 248.54 K | $310.74 K | 90.19% | 1.07% | |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2025 | 178.28 K | $411.84 K | 0.00% | 0.77% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 130.20 K | $300.76 K | 100.00% | 0.56% |
XTX TOPCO LTD | 08/12/2025 | 125.85 K | $290.71 K | 240.87% | 0.54% |
BELVEDERE TRADING LLC | 08/01/2025 | 114.50 K | $264.50 K | 100.00% | 0.49% |
MORGAN STANLEY | 08/15/2025 | 102.74 K | $237.32 M | 21.64% | 0.44% |
MASTERS CAPITAL MANAGEMENT LLC | 08/14/2025 | 100.00 K | $231.00 K | 100.00% | 0.43% |
CAPTION MANAGEMENT, LLC | 08/14/2025 | 100.00 K | $231.00 K | 100.00% | 0.43% |
08/14/2025 | 93.40 K | $116.77 K | 37.35% | 0.40% | |
NATIONAL BANK OF CANADA /FI/ | 08/18/2025 | 92.30 K | $213.20 K | 133.67% | 0.40% |
ORBIMED ADVISORS LLC | 08/14/2025 | 50.00 K | $115.50 K | 100.00% | 0.21% |
MYDA ADVISORS LLC | 08/13/2025 | 50.00 K | $115.50 K | 100.00% | 0.21% |
BUCKINGHAM STRATEGIC PARTNERS | 07/31/2025 | 48.81 K | $112.76 K | 321.20% | 0.21% |
ROYAL BANK OF CANADA | 08/14/2025 | 48.78 K | $113.00 M | 63.35% | 0.21% |
MAI CAPITAL MANAGEMENT | 08/12/2025 | 48.24 K | $111.43 K | -54.83% | 0.21% |
SCIENTECH RESEARCH LLC | 08/14/2025 | 45.74 K | $105.65 K | 100.00% | 0.20% |
LMR PARTNERS LLP | 08/14/2025 | 41.60 K | $96.10 K | 100.00% | 0.18% |
VIRTU FINANCIAL LLC | 08/12/2025 | 40.23 K | $93.00 K | 100.00% | 0.17% |
LAIRD NORTON TRUST COMPANY, LLC | 08/14/2025 | 37.00 K | $85.47 K | 1.09% | 0.16% |
GTS SECURITIES LLC | 08/08/2025 | 35.63 K | $82.30 K | 100.00% | 0.15% |
ATOM INVESTORS LP | 08/14/2025 | 22.54 K | $52.07 K | 100.00% | 0.10% |
OXFORD ASSET MANAGEMENT LLP | 08/14/2025 | 22.49 K | $51.95 K | 100.00% | 0.10% |
WESTSIDE INVESTMENT MANAGEMENT, INC. | 08/05/2025 | 21.38 K | $49.38 K | -76.04% | 0.09% |
COMMONWEALTH EQUITY SERVICES, LLC | 08/06/2025 | 16.91 K | $39.00 K | -15.00% | 0.07% |
08/12/2025 | 16.52 K | $38.16 K | 0.00% | 0.07% | |
FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 08/12/2025 | 15.50 K | $35.81 K | 0.00% | 0.07% |
MODERA WEALTH MANAGEMENT, LLC | 08/06/2025 | 15.46 K | $35.70 K | 100.00% | 0.07% |
PFG INVESTMENTS, LLC | 07/18/2025 | 11.50 K | $26.57 K | 100.00% | 0.05% |
FLPUTNAM INVESTMENT MANAGEMENT CO | 08/12/2025 | 11.49 K | $26.54 K | 100.00% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 08/08/2025 | 11.33 K | $26.17 K | 100.00% | 0.05% |
MARINER, LLC | 08/14/2025 | 10.88 K | $25.13 K | 100.00% | 0.05% |
SCULPTOR CAPITAL LP | 08/14/2025 | 10.40 K | $24.02 K | 100.00% | 0.04% |
BEACON POINTE ADVISORS, LLC | 08/13/2025 | 10.37 K | $23.95 K | 0.00% | 0.04% |
DAVENPORT & CO LLC | 07/22/2025 | 10.00 K | $23.10 K | 100.00% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2025 | 9.12 K | $21.06 K | 13.41% | 0.04% |
NEWEDGE ADVISORS, LLC | 08/14/2025 | 5.00 K | $11.55 K | 0.00% | 0.02% |
08/08/2025 | 3.36 K | $7.76 K | 0.00% | 0.01% | |
FMR LLC | 08/14/2025 | 2.51 K | $5.80 M | -15.57% | 0.01% |
POINT72 (DIFC) LTD | 08/14/2025 | 2.12 K | $4.90 K | 100.00% | 0.01% |
08/08/2025 | 1.63 K | $3.77 K | -0.67% | 0.01% | |
CRANBROOK WEALTH MANAGEMENT, LLC | 07/15/2025 | 1.05 K | $2.43 K | 0.00% | 0.00% |
07/18/2025 | 1.00 K | $4.55 K | 100.00% | 0.00% | |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2025 | 400 | $924 | 0.00% | 0.00% |
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. | 07/07/2025 | 106 | $244 | 35.90% | 0.00% |
SKOPOS LABS, INC. | 08/14/2025 | 90 | $208 | 100.00% | 0.00% |
INmune Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 72 institutional investors and hedge funds held shares of INmune Bio, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 1.17 M
RAYMOND JAMES FINANCIAL INC: 333,477
Rhenman & Partners Asset Management AB: 178,284
XTX Topco Ltd: 125,847
MORGAN STANLEY: 102,738
NATIONAL BANK OF CANADA /FI/: 92,300
24.10% of INmune Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.93 M shares in the last 24 months. This purchase volume represents approximately $11.64 M in transactions.